C92.50

HCC Category Mapping

What This Code Means

A rapidly developing blood cancer involving both myeloid and monocytic cells that has not achieved remission.

Coding Tips

• •Confirm the diagnosis includes both myeloid and monocytic differentiation
• •Document that remission has not been achieved; this indicates active, uncontrolled disease

Clinical Significance

Acute myelomonocytic leukemia (AMML, FAB M4) is an AML subtype characterized by proliferation of both myeloid and monocytic precursors, with at least 20% blasts and 20% or more monocytic cells in the bone marrow. The 'not in remission' status indicates active disease. AMML can be associated with eosinophilia (M4Eo variant with inv(16) or t(16;16)), which carries a more favorable prognosis within this subtype.

Documentation Requirements

• ✓Documentation must confirm the dual myeloid and monocytic differentiation on bone marrow examination. Cytogenetic results should be documented, particularly inv(16) or t(16
• ✓16) for the eosinophilic variant. Active disease status, blast percentage, and current treatment plan must be recorded. Extramedullary involvement (gingival hyperplasia, skin lesions common in monocytic leukemias) should be documented when present.

Commonly Confused Codes